Approval · Notice of Compliance 36039 · 2025
ELOCOM: Notice of Compliance 36039
Issued September 19, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36039
- Date
- September 19, 2025
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Monograph reformatted to the Master Template. Replacement of a drug product manufacturing site and/or manufacturer involving production. Replacement of a drug product manufacturing site and/or manufacturer involving primary packaging
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ELOCOM | Not yet assigned | — |
Medicinal ingredients
- MOMETASONE FUROATE 0.1 PER